BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 117 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $17,467,000 | -33.3% | 330,680 | -22.6% | 0.04% | -34.5% |
Q2 2020 | $26,187,000 | +21.7% | 427,430 | +12.4% | 0.06% | +3.6% |
Q1 2020 | $21,509,000 | +136.1% | 380,433 | +137.7% | 0.06% | +229.4% |
Q4 2019 | $9,109,000 | +216.5% | 160,024 | +198.1% | 0.02% | +183.3% |
Q3 2019 | $2,878,000 | +192.8% | 53,683 | +225.9% | 0.01% | +200.0% |
Q2 2019 | $983,000 | -15.3% | 16,471 | -11.3% | 0.00% | 0.0% |
Q1 2019 | $1,160,000 | -21.0% | 18,579 | -23.4% | 0.00% | -33.3% |
Q4 2018 | $1,469,000 | +30.3% | 24,258 | +26.0% | 0.00% | +50.0% |
Q3 2018 | $1,127,000 | -3.0% | 19,254 | -25.7% | 0.00% | 0.0% |
Q2 2018 | $1,162,000 | +169.6% | 25,917 | +166.1% | 0.00% | +100.0% |
Q1 2018 | $431,000 | +656.1% | 9,740 | +639.6% | 0.00% | – |
Q4 2017 | $57,000 | -76.1% | 1,317 | -74.3% | 0.00% | – |
Q3 2017 | $238,000 | -86.0% | 5,118 | -85.1% | 0.00% | -100.0% |
Q2 2017 | $1,697,000 | -10.1% | 34,266 | -0.5% | 0.00% | 0.0% |
Q1 2017 | $1,887,000 | +13.8% | 34,451 | +13.8% | 0.00% | 0.0% |
Q4 2016 | $1,658,000 | – | 30,280 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |